TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in <i>BRAF-</i> Mutant MelanomaRyan B. Corcoran, Jeffrey A. Engelman, Aaron N. Hata et al.|Science Translational Medicine|2013Cited by 138
Glucagon signaling via supraphysiologic GCGR can reduce cell viability without stimulating gluconeogenic gene expression in liver cancer cellsJason T. Godfrey, M. Celeste Simon|Cancer & Metabolism|2022Cited by 6